Test materials
The origin and characteristics of 4B7 (mouse anti-Pfs25 [13]), AB1245 (human anti-Pfs25 [14]), AB2544 (human anti-Pfs25 [15]), TB31F (human anti-Pfs48/45 [16]), and 15A4-1B12 (mouse anti-Pfs230 [17]) mAbs have been described elsewhere. The human serum and red blood cells used for the feeding experiments were purchased from Interstate Blood Bank (Memphis, TN, USA). The affinity-purified goat anti-mouse IgG (H+L) specific antibody for WB was purchased from Sera Care (Cat # 05-18-06, Milford, MA, USA). For ELISA, alkaline phosphatase labeled goat anti-human IgG (Cat # 075-1006) and alkaline phosphatase labeled goat anti-mouse IgG (Cat # 075-1806) antibodies were utilized (Kirkegaard & Perry Lab, Gaithersburg, MD, USA).
Mosquito feeding experiments
One hundred mL of uninfected human packed red blood cells (RBCs) were mixed with 100 mL of non-heat inactivated human serum and 60 mL of test mAb at 1 mg/ml in 1x phosphate buffered saline (1xPBS). The mAb concentration in the final mixture was 375 mg/mL in the liquid volume. The mixture was immediately fed to ~60 female An. stephensi mosquitoes (4-days-old) through a membrane-feeding apparatus, as performed for a standard membrane feeding assay (SMFA) described previously [18]. The mosquitoes were dissected (n=12 per time per assay) at indicated timepoints (from 0 to 48 hpf), and each midgut was collected in a tube with 20 mL of 1xPBS, snap frozen with dry ice, and kept at -80 ºC until used. The midguts without blood at the time of dissection were not collected. For each mAb, two or three independent experiments were performed, except 4B7, which were tested a total of 4 independent assays. For maintenance, mosquitoes were given 10% glucose solution ad libitum, except for the 15-18 hours of starvation before the feeds, and maintained in 75% humidity at 27 ºC throughout the experiments.
ELISA
The basic methodology of regular ELISA has been published elsewhere [19]. For anti-Pfs25 mAbs (4B7, AB1245 and AB2544), the ELISA plates were coated with Pfs25MF1E (a full-length Pfs25 recombinant protein [20]). For TB31F, R06C (6C-fragment of Pfs48/45 fused with GLURP antigen [21]) was used as a coating antigen, and Pfs230C1 (N-terminal of Pfs230 [17]) for 15A4-1B12 mAb. On the day of ELISA, for each mAb in each experiment, all midgut samples collected at multiple time points were thawed at the same time, homogenized by vortex, and diluted at mAb-specific dilutions (1:2,000 to 1:8,000 dilutions). The dilution factors were determined by preliminary experiments so the majority of 0 hpf samples showed ODs of 1.5-2 in the standardized assay at the optimized dilution. The thaw, homogenization and dilution steps were conducted within 1 hour, and ELISA was performed immediately after the sample preparation.
SDS-PAGE and Western blotting (WB)
The basic methodologies for SDS-PAGE and WB have been described elsewhere [22], and the assays were conducted only for 4B7 mAb samples. In brief, just before SDS-PAGE, all midgut samples from a single experiment were thawed at the same time, homogenized by vortex, mixed with LDS sample buffer (1:32.5 dilution), and loaded to a 4-12% Bis-Tris SDS-PAGE gel under non-reducing conditions. The dilution factor was determined by preliminary experiments, where all 0 hpf samples showed less than top saturation density in the WB at the 1:32.5 dilution. In each gel, 4 samples collected at each of all timepoints from a single experiment were loaded (e.g., 4 samples each at 0, 3, 20 and 27 hpf, a total of 16 samples were loaded into a single gel), and 3 to 4 gels were utilized per experiment. Following the SDS-PAGE, 4B7 mAb protein was transferred onto nitrocellulose membranes and was detected by the affinity-purified goat anti-mouse IgG (H+L) specific antibody (1:2,000 dilution). The band density of each sample was quantified using Amersham Imager 680 (GE Healthcare, Chicago, IL, USA). Serial dilutions of known concentrations of 4B7 mAb in RBCs and human serum mixtures were processed in the same way to generate a standard curve, and a density value of test sample was converted to 4B7 mAb concentrations using the standard curve.
Statistical analysis
For the WB results, in each blot, an arithmetic mean of 4B7 mAb concentration of 0 hpf samples (4 samples in each blot) was calculated, and a relative 4B7 mAb concentration of test sample from the other timepoints in the same blot was determined as percent (%) relative to the average 0 hpf value (%0hpf). Similar to the WB analysis, ELISA result of each non-0-hpf sample was converted to %0hpf by calculating the relative amount against the average 0 hpf samples in the same experiment (12 samples in each experiment). If the antibody concentrations were too low to determine (i.e, less than the minimal detection limit of assay), %0hpf value was assigned as zero, and the lowest positive values were 0.04 %0hpf for WB and 1.9 %0hpf for ELISA. To determine the best-estimate of half-life (and the 95% confidence interval, 95%CI), the %0hpf values were plotted against their hpf values individually, and a one-phase exponential decay model was utilized to determine the best-fit curve. To compare half-life of 4B7 between ELISA and WB, a F-test was used. An F-test was utilized to compare half-lives of two mAbs (only for ELISA data) at a time, then Bonferroni corrected p-values were calculated to adjust for multiple comparisons. All statistical tests were performed in Prism 8 (GraphPad Software), and p-values <0.05 were considered significant.